Form 15-12G Acreage Holdings, Inc.
Tweet
Share
E-mailUNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________ FORM 15 ____________________________ CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 000-56021 ____________________________ ACREAGE HOLDINGS, INC. (Exact name of registrant as specified in its charter) ____________________________ 366 Madison Ave, 14th floor New York, New York 10017 (646) 600-9181 (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) Class D Subordinate Voting Shares, no par value Class E Subordinate Voting Shares, no par value (Title of each class of securities covered by this Form) None (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains) | ||
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1) | ☒ | |||||||
Rule 12g-4(a)(2) | ☐ | |||||||
Rule 12h-3(b)(1)(i) | ☒ | |||||||
Rule 12h-3(b)(1)(ii) | ☐ | |||||||
Rule 15d-6 | ☐ | |||||||
Rule 15d-22(b) | ☐ | |||||||
Approximate number of holders of record as of the certification or notice date: One.
Pursuant to the requirements of the Securities Exchange Act of 1934, Acreage Holdings, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
| Acreage Holdings, Inc. | ||||||||||||||||||||
| Date: December 9, 2024 | By: | /s/ Corey Sheahan | ||||||||||||||||||
| Corey Sheahan | ||||||||||||||||||||
| Executive Vice President, General Counsel and Secretary | ||||||||||||||||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Why Bank Remediation Falls Short When Institutions Treat Findings in Isolation
- Candel Therapeutics to Present Extended Data from Phase 3 Results of Aglatimagene Besadenovec at ASTRO 2026
- Yakira Capital Management Urges People Board to Withdraw MGM Acquisition Proposal and Prioritize Share Repurchases
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
